C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis

20:13 EDT 15 Jun 2018 | Nature Publishing

More From BioPortfolio on "C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis"